AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bitaquine DS 500mg Tablet

Prescription Icon
Prescription Required

Marketer

Bombay Tablet Mfg Co Pvt Ltd

Salt Composition

Chloroquine (500mg)

Overview Bitaquine DS 500mg Tablet

Malarone 500mg tablets combat malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the malaria-causing organism, halting infection spread. Dosage and treatment duration should strictly adhere to your physician's instructions. Ingestion with food mitigates potential stomach discomfort. Consistent medication is crucial; complete the prescribed course regardless of symptom improvement. Premature cessation risks treatment failure and amplified side effects. Avoid doubling doses to compensate for missed ones; simply resume the regular schedule. Mosquito bite prevention is vital: utilize insect repellent on exposed skin, spray repellents indoors, and wear light-colored, protective clothing after dusk. Potential side effects include rash, headache, dizziness, vomiting, abdominal pain, diarrhea, anorexia, and nausea. Persistent side effects warrant immediate medical consultation. Diabetics should inform their doctor, as Malarone can reduce blood sugar levels, necessitating regular monitoring. Blurred vision is possible, prompting routine eye exams during treatment. Long-term use may necessitate regular blood cell count monitoring. Report any unexplained bruising, bleeding, sore throat, fever, or fatigue to your doctor immediately.

Uses of Bitaquine DS 500mg Tablet

Managing Malaria Infections

Major Benefits of Bitaquine DS 500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Bitaquine DS 500mg Tablet with a meal.

Common Side effects of Bitaquine DS 500mg Tablet:

  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Bitaquine DS 500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bitaquine DS 500mg tablets should be administered with a meal.

How Bitaquine DS 500mg Tablet works:

Malaria is effectively combated by Bitaquine DS 500mg Tablets, an antiparasitic drug. Its mechanism involves elevating blood heme concentrations, a substance harmful to the malaria parasite. This heightened toxicity eradicates the parasite, thus halting the infection's progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of combining alcohol with Bitaquine DS 500mg Tablet is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Bitaquine DS 500mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactating individuals may safely use Bitaquine DS 500mg tablets. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Bitaquine DS 500mg Tablets. These side effects can include blurred vision and difficulty focusing, both of which could impact safe driving.

KidneyKidneyCAUTION

Patients with kidney impairment should use Bitaquine DS 500mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Bitaquine DS 500mg Tablets, as dosage modification may be necessary. Consult your physician for guidance. Routine liver function assessments are recommended during treatment with this medication.

What if you forget to take Bitaquine DS 500mg Tablet :

Should you forget a Bitaquine DS 500mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bitaquine DS 500mg Tablet

LabelValue
Type of Compound A compound derived from 4-aminoquinoline.
Potential for Dependence None.
Type of Treatment Eye medication.
Mechanism of Action Aminoquinoline antimalarials

FAQs on Bitaquine DS 500mg Tablet

Bitaquine DS 500mg tablets are an antimalarial medication employed in both the treatment and prophylaxis of malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. The incubation period typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, presenting as chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Bitaquine DS 500mg Tablets, as directed by your physician, necessitates regular eye examinations. This is a precaution due to the chloroquine content, which can induce blurred vision, reading difficulties (manifesting as words seemingly disappearing), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to commencing treatment with Bitaquine DS 500mg Tablets, as it could potentially exacerbate the condition.
This medication may cause abdominal discomfort, queasiness, emesis, and cephalalgia in some individuals. These adverse reactions frequently lessen when the medication is administered with food.
Insufficient clinical evidence supports chloroquine's efficacy against COVID-19. Consequently, using Bitaquine DS 500mg tablets for this purpose should only occur under a physician's guidance.
Allow at least four hours between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially received approval as malaria treatments. Nevertheless, chloroquine is associated with a significantly higher incidence of adverse reactions compared to hydroxychloroquine. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, hydroxychloroquine's therapeutic applications extend to rheumatoid arthritis and lupus, unlike chloroquine.
Mosquito-borne malaria can be avoided through protective measures such as wearing long sleeves and trousers, employing mosquito netting, and applying insect repellent. Consult your physician regarding the necessity of antimalarial medication. If prescribed, adhere strictly to the recommended dosage and complete the full course of treatment.
Bitaquine DS 500mg tablets are an antimalarial drug indicated for malaria prophylaxis and treatment.
Malaria symptoms can emerge within a week of an infected mosquito bite. More commonly, these symptoms manifest between seven and eighteen days post-infection. Initial symptoms resemble influenza, encompassing chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Patients prescribed Bitaquine DS 500mg Tablets for extended durations should undergo routine eye examinations. Prolonged use of the chloroquine component may lead to blurred vision, reading difficulties stemming from apparent word loss, and, infrequently, retinopathy.
Consult your physician about your psoriasis prior to commencing treatment with Bitaquine DS 500mg Tablets, as it could potentially exacerbate your condition.
Abdominal discomfort, nausea, vomiting, and headache are frequently reported adverse reactions associated with this medication. Ingesting the medication with food may often lessen these effects.
Insufficient clinical evidence supports the use of chloroquine for COVID-19 treatment. Consequently, Bitaquine DS 500mg Tablet should not be used for this purpose without prior physician consultation.
Allow at least four hours between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially received regulatory approval for malaria treatment. Nevertheless, chloroquine's side-effect profile is considerably more extensive than that of hydroxychloroquine. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, hydroxychloroquine holds approvals for rheumatoid arthritis and lupus, indications for which chloroquine lacks approval.
Mosquito-borne malaria can be avoided through preventative measures such as wearing protective clothing to minimize bites, employing mosquito nets, and using insect repellent. Consult your physician regarding the necessity of antimalarial medication. If prescribed, ensure accurate dosage and completion of the full treatment regimen.
Bitaquine DS 500mg Tablet
6
MRP 7
19% off